Please use this identifier to cite or link to this item:
|Title:||Purulent pneumococcal pericarditis, a vaccine-preventable illness.||Austin Authors:||Rees, Matthew J ;Wilson, Andrew||Affiliation:||Department of Haematology, Austin Health, Heidelberg, Victoria, Australia
Department of Cardiology, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
|Issue Date:||Aug-2019||metadata.dc.date:||2019-08-29||Publication information:||Oxford medical case reports 2019; 2019(8): omz078||Abstract:||A 74-year-old gentleman presented to hospital with a 1-day history of acute onset pleuritic chest pain and fever. He was found to have widespread ST segment elevation on electrocardiogram, and blood cultures taken were positive for Streptococcus pneumoniae. Two days following admission the patient developed dyspnea, and a large pericardial effusion and right middle lobe consolidation were demonstrated on a computed tomography scan of the chest. A transthoracic echocardiogram confirmed the presence of a large circumferential pericardial effusion with multiple prominent adhesions and marked heterogenous thickening of the pericardium, without evidence of tamponade. Pericardiocentesis drained a purulent exudate positive for pneumococcal antigen. The occurrence of purulent pericarditis secondary to pneumococcal community-acquired pneumonia is rare in the modern antibiotic era and represents an often-lethal manifestation of invasive pneumococcal disease (IPD). IPD is a vaccine-preventable illness for which adult vaccination rates are low despite high morbidity. Healthcare professionals need to vaccinate older patients opportunistically.||URI:||http://ahro.austin.org.au/austinjspui/handle/1/22211||DOI:||10.1093/omcr/omz078||PubMed URL:||31772745||ISSN:||2053-8855||Type:||Journal Article|
|Appears in Collections:||Journal articles|
Show full item record
checked on Nov 30, 2022
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.